Artificial blood developed for patients of any blood type:The Asahi Shimbun. (2019, September 29). Asahi
Hagisawa, K., Kinoshita, M., Takikawa, M., Takeoka, S., Saitoh, D., Seki, S., & Sakai, H. (2019). Combination therapy using fibrinogen γ‐chain peptide‐coated, ADP‐encapsulated liposomes and hemoglobin vesicles for trauma‐induced massive hemorrhage in thrombocytopenic rabbits. Transfusion, 59(10), 3186–3196. doi: 10.1111/trf.15427